BioAg of the Future: The Digest’s 2019 Multi-Slide Guide to Novozymes BioAg

Novozymes is the world leader in biological solutions focusing on enzymes and microbes. Since 2000, they have brought more than 100 new molecules to market to address specific industry and customer challenges. We account for 2/3 of the entire global investment in developing enzymes, and dedicate 13-14% of our total revenue to R&D. With 48% market share in industrial enzymes, they deliver bioinnovation to 130 countries and manufacture across North America, South America, Europe and Asia.

Tina Sejersgard Fane, EVP of Agriculture and Bioenergy and Prisca Havranek-Kosicek, CFO & EVP at Novozymes, gave this illuminating overview of the their continuation with Bayer as a core partner for their BioAg business, the new setup with more partners and more, at ABLC Global 2018 in San Francisco